OnePath® co-pay assistance program*

FIRAZYR is a medicine used to treat acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

The OnePath Co-Pay Assistance Program helps eligible patients cover certain out-of-pocket treatment costs. The program provides 100% coverage of eligible costs (up to the program maximum), which may include deductibles, co-pays, and co-insurance.

At a minimum, you must be enrolled in OnePath and have commercial insurance to be eligible for the OnePath Co-Pay Assistance Program. Other eligibility requirements apply.

*IMPORTANT NOTICE: The OnePath Copay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs). No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third party payer, whether public or private. The Program cannot be combined with any other rebate/coupon, free trial, or similar offer. Copayment assistance under the Program is not transferable. The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your insurance provider. If your insurance situation changes you must notify the Program immediately at 1-866-888-0660. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice.

Additional program restrictions and eligibility requirements apply. Not valid for prescriptions eligible to be reimbursed by Medicaid, Medicare, or other state or federal programs. Offer good only in the United States. Offer void where prohibited by law, taxed, or restricted. Takeda reserves the right to rescind, revoke, or amend this offer at any time without notice.

Subject to program terms, limits, and conditions.

What is FIRAZYR?

FIRAZYR is prescribed to treat acute HAE attacks in adults 18 years of age and older.

Get the facts »

How to Use FIRAZYR

See how to inject FIRAZYR to treat symptoms of an acute HAE attack.

Watch video »